NIH Funding Opportunities

Updated:Oct 27,2014

NIH award program information is provided as a courtesy.  When you click on the links below, you will be leaving the AHA's website.

Funding Opportunity Announcement: 2015 NIH Director’s Early Independence Awards

The National Institutes of Health Common Fund announces the FY 2015 funding opportunity for the NIH Director’s Early Independence Awards (EIA).  The EIA initiative allows exceptional junior scientists to accelerate their transition to an independent research career by “skipping” the traditional postdoctoral training. To be eligible, candidates must be within one year (before or after) of completion of their terminal degree or clinical residency at the time of application.  Each institution (as defined by a unique DUNS identifier) may submit up to two applications in response to this FOA. Letters of intent are due Dec. 30, 2014. Applications are due January 30, 2015. See the instructions in the Funding Opportunity Announcement (RFA-RM-14-004).

To facilitate the “matching” of prospective candidates with potential host institutions, the NIH Common Fund has created a matching portal website in which institutions may indicate their interest in hosting EIA awardees and provide pertinent information. Prospective candidates will be able to use this portal to identify potential host institutions. Institutions are invited to provide information as soon as they are able. The portal will be updated on a continuing basis. Note that while registration by institutions is encouraged, it is not required and candidates may identify host institutions through other means.

Responses to Frequently Asked Questions about the Early Independence Awards initiative are available at http://commonfund.nih.gov/earlyindependence/faq

The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers and Offices. Additional information about the NIH Common Fund can be found at http://commonfund.nih.gov.

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
__________________________________________________________________________________________ 

NHLBI announces Notice of Intent to Publish a Funding Opportunity Announcement


NHLBI has announced a Funding Opportunity for Testing of Multi-Level Interventions to Improve Blood Pressure Control in Racial/Ethnic Minority, Low Socioeconomic Status, and/or Rural Populations (UH2/UH3).

Earliest Publication Date of Announcement: November 2014
First Estimated Application Due Date: January 2015

For more information about this funding opportunity, visit NOT-HL-14-238.

 __________________________________________________________________________________________ 


NHLBI announces Topics of Special Interest (TOSI)
 
NHLBI has announced special areas of interest per the announcement below.  Applicants are encouraged to discuss ideas with NHLBI Officers on the following topics:
  • Development Pathways in the Pathogenesis of Adult Chronic Lung Diseases
  • Advancing Research in Exercise Therapy for Chronic Heart Failure
  • Phenotypic Characterization of Chronic Pain in Sickle Cell Disease
Though funds are not set aside for these topics, they are eligible for special funding consideration.

For more information, check http://grants.nih.gov/grants/guide/notice-files/NOT-HL-13-201.html.

__________________________________________________________________________________________ 


Funding Opportunity Announcement: 2014 NIH Defining a Comprehensive Reference Profile of Circulating Human Extracellular RNA (U01)

The NIH Common Fund welcomes applications to generate a comprehensive reference profile of extracellular RNA from normal and healthy human body fluids.  The purpose of this Funding Opportunity Announcement (RFA-RM-13-014) (http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-014.html) is to support projects that will generate reference profiles of both short and long non-coding regulatory extracellular RNA (exRNA), including any environmentally-derived exRNA (e.g. from diet, microbiome), from a diversity of healthy human body fluids including blood, saliva, urine, breast milk, semen, amniotic fluid, cerebrospinal fluid, ascites and pleural effusions.  It is anticipated that such a reference profile will enable the scientific community to further elucidate the roles of exRNA in human physiology, and may subsequently facilitate disease diagnosis and therapeutic outcomes. Studies using existing human biospecimen collections are strongly encouraged.
  • Projects will be supported up to $700,000 total cost per year, for up to five years
  • Informational webinar:  October 9, 2013 1pm – 3pm Eastern Time (https://ncatsmeetings.webex.com/ncatsmeetings/j.php?J=738416820&PW=NYWEwNWYzMGNm)
  • Letter of Intent (LOI) due date:  October 22, 2013
  • Application due date:  November 22, 2013 by 5pm local time of applicant organization
  • For questions, please see FAQs (http://commonfund.nih.gov/Exrna/faq.aspx) or direct specific concerns to the Program Director listed in the Funding Opportunity Announcement.
  • This RFA is one component of the Common Fund’s Extracellular RNA Communication (ERC) program, which has been developed to address critical issues in this nascent field. The goal of this program is to explore entirely new paradigms of intercellular signaling based on the release, transport, uptake, and regulatory role of exRNAs. For more information about the ERC program, please visit the program website (http://commonfund.nih.gov/exrna/overview.aspx).


The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices. Additional information about the NIH Common Fund can be found at http://commonfund.nih.gov.

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

__________________________________________________________________________________________ 
 

Funding Opportunity Announcement: 2014 NIH Director’s Early Independence Awards
 
The National Institutes of Health Common Fund announces the FY 2014 funding opportunity for the NIH Director’s Early Independence Awards (EIA). The EIA initiative allows exceptional junior scientists to accelerate their transition to an independent research career by “skipping” the traditional postdoctoral training. To be eligible, candidates must be within one year (before or after) of completion of their terminal degree or clinical residency at the time of application. Each institution (as defined by a unique DUNS identifier) may submit up to two applications in response to this FOA. Letters of intent are due Dec. 31, 2013. Applications are due January 31, 2014. See the instructions in the Funding Opportunity Announcement (RFA-RM-13-009).

To facilitate the “matching” of prospective candidates with potential host institutions, the NIH Common Fund has created a website (http://commonfund.nih.gov/earlyindependence/matchingportal/index.aspx) in which institutions may indicate their interest in hosting EIA awardees and provide pertinent information. This website will be updated periodically as institutions provide information. Interested institutions are encouraged to provide information on the website by October 1, 2013. Prospective candidates may visit this website to determine which institutions are interested in hosting candidates and follow up directly with institutions accordingly. Note that while registration by institutions is encouraged, it is not required and institutions and candidates may match through other means.

Responses to Frequently Asked Questions about the Early Independence Awards initiative are available at http://commonfund.nih.gov/earlyindependence/faq2014.aspx. An informational webinar has been scheduled for Oct. 10, 2013. Additional webinar details will be posted on the EIA website when they become available. Send questions about the EIA initiative to earlyindependence@mail.nih.gov.

The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers and Offices. Additional information about the NIH Common Fund can be found at http://commonfund.nih.gov.

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

__________________________________________________________________________________________ 

Funding Opportunity Announcement - 2014 NIH Transformative Research Awards

Announcing a funding opportunity for the NIH Transformative Research Awards (RFA-RM-13-008):

  • Exceptionally innovative, high risk, original and/or unconventional research with broad impact
  • Individual or multi-PI applications permitted
  • Clinical, basic, and/or behavioral/social science research projects
  • Large budget applications welcome

Letter of Intent due September 4, 2013.
Applications due October 4, 2013.

For more information about the Transformative Research Project, view the FAQs page.
Send questions to Transformative_Awards@mail.nih.gov.

The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers and Offices. Additional information about the NIH Common Fund can be found at http://commonfund.nih.gov.

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

______________________________________________________________________________________________

 
Funding Opportunity Announcement - NIH Common Fund Epigenomics Program
 
The National Institutes of Health (NIH) Common Fund has issued a new Funding Opportunity Announcement (FOA) for the Epigenomics program. The overall goals of the Epigenomics program are to generate new tools, technologies, data sets and infrastructure to accelerate our understanding of the occurrence and function of epigenomic modifications in normal development and in a wide variety of diseases. The new Functional Epigenomics FOA (RFA-RM-12-026) seeks applications to develop tools and technologies enabling specific manipulation of the epigenome across space (tissue-, cell-, and locus-specific manipulation) and/or time (temporally-specific manipulation).
 
Functional Epigenomics: Developing Tools and Technologies for Cell-type, Temporal, or Locus-specific Manipulation of the Epigenome (R01) (RFA-RM-12-026) has a letter of intent due date of February 27, 2013. The application receipt date is March 27, 2013. The maximum award is $325,000 in direct costs.
 
The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers and Offices. Additional information about the NIH Common Fund.
 
The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

______________________________________________________________________________________________

 
Information on a Funding Opportunity Announcement for the NIH “Strengthening the Biomedical Research Workforce” program
 
The NIH Common Fund’s Strengthening the Biomedical Research Workforce program announces a new Funding Opportunity Announcement (RFA-RM-12-022) to solicit applications for the Broadening Experiences in Scientific Training (BEST) awards that will support the development of novel graduate and postdoctoral training activities intended to expose trainees to diverse career options. We will have an informational webinar to describe the program and answer questions on March 26, 2013 from 3:00pm-4:00pm EDT. For more information about this webinar and to register, please visit https://www4.gotomeeting.com/register/218085999.
 
This program was developed in response to recommendations of the Advisory Committee to the Director (ACD) Working Group on Biomedical Workforce. The committee studied the current state of the biomedical research workforce, and NIH’s support of its training (http://acd.od.nih.gov/Biomedical_research_wgreport.pdf).
 
The purpose of this FOA is to identify and support bold and innovative approaches to broaden and complement traditional research training in biomedical, behavioral, social, and clinical (referred to as “biomedical”) sciences to better prepare graduate students and postdoctoral scientists for a wide range of career options in biomedical research. These include research or research-related occupations in the private sector, government, and academia. Collaborations with non-academic partners are encouraged to ensure that experts from a broad spectrum of careers contribute to coursework, rotations, internships or other forms of exposure. Awardee institutions will establish a network to disseminate best practices within the training community.
                              
Key features of the FOA
 
  • The program seeks innovative approaches to complement traditional research training. 
  • The program encourages institutions to leverage funds across their existing training activities, and with corporate, government, and other potential employers.
  • Programs must have the potential to engage all biomedical PhD students and postdocs at the institution.
  • Awards can be for up to $250,000 per year direct costs for 5 years plus full indirect costs; stipend support is not allowable.
  • There will be an emphasis on measurable program objectives and outcome analyses.
  • Awards are non-renewable, with the expectation that institutions will develop new academic and business models that allow the programs to be sustained beyond the period of this award.
  • Applications will be reviewed by appropriate Scientific Review Groups in the Center for Scientific Review.
  • NIH expects to make 8-10 BEST awards in 2013.
 
See more details on the Strengthening the Biomedical Research Workforce program.
 
Webinar:  March 26, 3-4:00 PM EDT.  Go here for more information and to register.
Please submit questions in advance to: Workforce_Award@mail.nih.gov.
 
Letter of Intent due April 10, 2013
Submission Date: May 10, 2013
Earliest Start Date: Sept 16, 2013
Please distribute this information to colleagues who may be interested in the program.
 
The NIH Common Fund supports goal-driven, research networks in which investigators generate data, solve technological problems, and/or otherwise pilot resources and tools that will be stimulatory to the broader research community. Common Fund programs are designed to achieve their goals within a maximum of 10 years. More information about the programs currently supported by the Common Fund can be found at www.commonfund.nih.gov.